Showing results (131-140 of 305) with videos related to

Sort By:
Pageof 31
Journal of Cell Science|February 8, 2017
The Rap1-cofilin-1 pathway coordinates actin reorganization and MTOC polarization at the B cell immune synapseJia C Wang, Jeff Y-J Lee, Sonja Christian, et al.
Heart Rhythm|June 19, 2010
Randomized comparison of defibrillation thresholds from the right ventricular apex and outflow tractCarl R Reynolds, Vladimir Nikolski, J Lacy Sturdivant, et al.
American Heart Journal|May 27, 2003
Effect of an implantable cardioverter defibrillator with atrial detection and shock therapies on patient-perceived, health-related quality of lifeDavid M Newman, Paul Dorian, Miney Paquette, et al.
Heart Rhythm|February 15, 2011
Temporal stability of defibrillation thresholds with cardiac resynchronization therapyMichael R Gold, Amir Hedayati, Jamshid Alaeddini, et al.
American Heart Journal|June 20, 2012
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HFPaul J Hauptman, Peter J Schwartz, Michael R Gold, et al.
Circulation|July 12, 2012
Effect of QRS duration and morphology on cardiac resynchronization therapy outcomes in mild heart failure: results from the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) studyMichael R Gold, Christophe Thébault, Cecilia Linde, et al.
Heart Rhythm|December 3, 2014
The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE studyMichael R Gold, Claude Daubert, William T Abraham, et al.
Heart Rhythm|December 21, 2011
Potential mechanisms underlying the effect of gender on response to cardiac resynchronization therapy: insights from the SMART-AV multicenter trialAlan Cheng, Michael R Gold, Alan D Waggoner, et al.
Circulation. Arrhythmia and Electrophysiology|October 16, 2013
Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE)Michael R Gold, Jean-Claude Daubert, William T Abraham, et al.
European Journal of Heart Failure|March 19, 2014
Long-term effectiveness of the combined minute ventilation and patient activity sensors as predictor of heart failure events in patients treated with cardiac resynchronization therapy: Results of the Clinical Evaluation of the Physiological Diagnosis Function in the PARADYM CRT device Trial (CLEPSYDRA) studyAngelo Auricchio, Michael R Gold, Josep Brugada, et al.
Pageof 31